Schroetter Syndrome: Effort-Induced Upper Extremity DVT Explained
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), posted on LinkedIn:
”Schroetter Syndrome Effort Induced Upper Extremity Deep Vein Thrombosis
Paget-Schroetter syndrome (PSS), also known as “effort thrombosis,” represents a primary form of upper extremity deep vein thrombosis (UEDVT) typically arising in young, healthy, and active individuals following strenuous or repetitive upper limb exertion.
Recognized as the venous subtype of thoracic outlet syndrome (TOS), PSS occurs due to mechanical compression of the subclavian vein within the costoclavicular space, often potentiated by structural anomalies such as cervical ribs, hypertrophied scalene muscles, or aberrant ligamentous insertions. The pathophysiology integrates Virchow’s triad, with endothelial trauma, venous stasis, and hypercoagulability converging to precipitate thrombosis.
Clinically, PSS presents with sudden upper extremity swelling, pain, heaviness, and cyanosis, often following athletic or occupational activity. Diagnosis requires high clinical suspicion and confirmation with duplex ultrasonography, venography, or advanced cross-sectional imaging, while laboratory investigations may identify concomitant thrombophilic disorders.
Management strategies emphasize multimodal therapy: immediate anticoagulation, catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy for clot clearance, and surgical thoracic outlet decompression to correct the underlying anatomical cause. Long-term outcomes are optimized by interdisciplinary collaboration involving vascular surgeons, radiologists, internists, and rehabilitation specialists.
Despite advances in endovascular and surgical techniques, controversies remain regarding timing of decompression, duration of anticoagulation, and management of chronic venous occlusion. With appropriate treatment, recanalization rates of 75–90% are achievable, preventing long-term complications such as recurrent thrombosis, pulmonary embolism, and postthrombotic syndrome.
Future research should focus on refining minimally invasive strategies, optimizing patient selection for surgical intervention, and developing preventive approaches for high-risk athletic populations.”
Read the full article here.
Author: Indunil Karunarathna
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE